SAHILY ANDREU GUERRA: Open Payments
NPI 1144704578 · HIALEAH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,315 in 76 payments from 12 companies in 2025. Trend: 2023 $2,174 · 2024 $1,826 · 2025 $1,315
Food & beverage: $1,315
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 26 | $363 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $196 |
| Alkermes, Inc. | 11 | $157 |
| Neurocrine BioSciences, Inc. | 5 | $120 |
| ABBVIE INC. | 5 | $75 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Lundbeck LLC | 2 | $42 |
| Almatica Pharma LLC | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: REXULTI, TRINTELLIX, CAPLYTA, ARISTADA, INGREZZA, VRAYLAR, Auvelity, LOREEV XR.
Industry payments across FL — which companies pay providers there.
